{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:46:26Z","timestamp":1787237186205,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,25]]},"DOI":"10.7759\/cureus.65347","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T11:05:36Z","timestamp":1721905536000},"source":"Crossref","is-referenced-by-count":2,"title":["Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Prinka","family":"Perswani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritesh Croos","family":"Yogarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Saifuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Lakhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagruti","family":"Dasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanshika","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ojasvi","family":"Raina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Jomy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pracruti","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Pasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Tayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasim","family":"Reza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.38101","article-title":"Targeted molecular investigation in patients within the clinical spectrum of Auriculocondylar syndrome","volume":"173","author":"Romanelli Tavares VL","year":"2017","unstructured":"Romanelli Tavares VL, Zechi-Ceide RM, Bertola DR, et al.. Targeted molecular investigation in patients within the clinical spectrum of Auriculocondylar syndrome. Am J Med Genet A. 2017, 173:938-45. 10.1002\/ajmg.a.38101","journal-title":"Am J Med Genet A"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad226","article-title":"Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal","volume":"25","author":"Lip GY","year":"2023","unstructured":"Lip GY, Proietti M, Potpara T, et al.. Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal. Europace. 2023, 25:euad226. 10.1093\/europace\/euad226","journal-title":"Europace"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2021.07.009","article-title":"Epidemiology of atrial fibrillation-related ischemic stroke and its association with DOAC uptake in Spain: first national population-based study 2005 to 2018","volume":"75","author":"D\u00edaz-Guzm\u00e1n J","year":"2022","unstructured":"D\u00edaz-Guzm\u00e1n J, Freixa-Pamias R, Garc\u00eda-Alegr\u00eda J, et al.. Epidemiology of atrial fibrillation-related ischemic stroke and its association with DOAC uptake in Spain: first national population-based study 2005 to 2018. Rev Esp Cardiol (Engl Ed). 2022, 75:496-505. 10.1016\/j.rec.2021.07.009","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof P","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, et al.. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016, 37:2893-962. 10.1093\/eurheartj\/ehw210","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euab092","article-title":"The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review","volume":"23","author":"Stevens D","year":"2021","unstructured":"Stevens D, Harrison SL, Kolamunnage-Dona R, Lip GY, Lane DA. The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review. Europace. 2021, 23:1511-27. 10.1093\/europace\/euab092","journal-title":"Europace"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303048","article-title":"Early versus later anticoagulation for stroke with atrial fibrillation","volume":"388","author":"Fischer U","year":"2023","unstructured":"Fischer U, Koga M, Strbian D, et al.. Early versus later anticoagulation for stroke with atrial fibrillation. N Engl J Med. 2023, 388:2411-21. 10.1056\/NEJMoa2303048","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to improve AF management","volume":"14","author":"Lip GY","year":"2017","unstructured":"Lip GY. The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol. 2017, 14:627-8. 10.1038\/nrcardio.2017.153","journal-title":"Nat Rev Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1523","article-title":"Interventions for preventing thromboembolic events in patients with atrial fibrillation: a systematic review","volume":"169","author":"Lowenstern A","year":"2018","unstructured":"Lowenstern A, Al-Khatib SM, Sharan L, et al.. Interventions for preventing thromboembolic events in patients with atrial fibrillation: a systematic review. Ann Intern Med. 2018, 169:774-87. 10.7326\/M18-1523","journal-title":"Ann Intern Med"},{"key":"ref9","article-title":"Indications for anticoagulation in atrial fibrillation","volume":"58","author":"Akhtar W","year":"1998","unstructured":"Akhtar W, Reeves WC, Movahed A. Indications for anticoagulation in atrial fibrillation. Am Fam Physician. 1998, 58:130-6.","journal-title":"Am Fam Physician"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.01.017","article-title":"Emerging tools for stroke prevention in atrial fibrillation","volume":"4","author":"Voukalis C","year":"2016","unstructured":"Voukalis C, Lip GY, Shantsila E. Emerging tools for stroke prevention in atrial fibrillation. EBioMedicine. 2016, 4:26-39. 10.1016\/j.ebiom.2016.01.017","journal-title":"EBioMedicine"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2021.12.001","article-title":"Atrial fibrillation and stroke: a review and new insights","volume":"33","author":"Escudero-Mart\u00ednez I","year":"2023","unstructured":"Escudero-Mart\u00ednez I, Morales-Caba L, Segura T. Atrial fibrillation and stroke: a review and new insights. Trends Cardiovasc Med. 2023, 33:23-9. 10.1016\/j.tcm.2021.12.001","journal-title":"Trends Cardiovasc Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/14779072.2023.2160319","article-title":"Atrial fibrillation and stroke","volume":"21","author":"Choi SE","year":"2023","unstructured":"Choi SE, Sagris D, Hill A, Lip GY, Abdul-Rahim AH. Atrial fibrillation and stroke. Expert Rev Cardiovasc Ther. 2023, 21:35-56. 10.1080\/14779072.2023.2160319","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2021.1897786","article-title":"Drugs in phase I and II clinical development for the prevention of stroke in patients with atrial fibrillation","volume":"30","author":"Bentley R","year":"2021","unstructured":"Bentley R, Hardy LJ, Scott LJ, Sharma P, Philippou H, Lip GY. Drugs in phase I and II clinical development for the prevention of stroke in patients with atrial fibrillation. Expert Opin Investig Drugs. 2021, 30:1057-69. 10.1080\/13543784.2021.1897786","journal-title":"Expert Opin Investig Drugs"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-314898","article-title":"Stroke and thromboembolism prevention in atrial fibrillation","volume":"106","author":"Jame S","year":"2020","unstructured":"Jame S, Barnes G. Stroke and thromboembolism prevention in atrial fibrillation. Heart. 2020, 106:10-7. 10.1136\/heartjnl-2019-314898","journal-title":"Heart"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57050444","article-title":"Percutaneous left atrial appendage occlusion: an emerging option in patients with atrial fibrillation at high risk of bleeding","volume":"57","author":"Cimmino G","year":"2021","unstructured":"Cimmino G, Loffredo FS, Gallinoro E, et al.. Percutaneous left atrial appendage occlusion: an emerging option in patients with atrial fibrillation at high risk of bleeding. Medicina (Kaunas). 2021, 57:444. 10.3390\/medicina57050444","journal-title":"Medicina (Kaunas)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/07853890701320662","article-title":"Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices","volume":"39","author":"Savelieva I","year":"2007","unstructured":"Savelieva I, Bajpai A, Camm AJ. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices. Ann Med. 2007, 39:371-91. 10.1080\/07853890701320662","journal-title":"Ann Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001112","article-title":"Management of acute coronary syndrome in the older adult population: a scientific statement from the American Heart Association","volume":"147","author":"Damluji AA","year":"2023","unstructured":"Damluji AA, Forman DE, Wang TY, et al.. Management of acute coronary syndrome in the older adult population: a scientific statement from the American Heart Association. Circulation. 2023, 147:e32-62. 10.1161\/CIR.0000000000001112","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026645","article-title":"Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011-2016","volume":"9","author":"Maura G","year":"2019","unstructured":"Maura G, Billionnet C, Drouin J, Weill A, Neumann A, Pariente A. Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011-2016. BMJ Open. 2019, 9:e026645. 10.1136\/bmjopen-2018-026645","journal-title":"BMJ Open"},{"key":"ref20","article-title":"Warfarin","author":"Patel S","year":"2024","unstructured":"Patel S, Singh R, Preuss CV, Patel N. Warfarin. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2015.04.140297","article-title":"Novel anticoagulants in atrial fibrillation: a primer for the primary physician","volume":"28","author":"Mookadam M","year":"2015","unstructured":"Mookadam M, Shamoun FE, Mookadam F. Novel anticoagulants in atrial fibrillation: a primer for the primary physician. J Am Board Fam Med. 2015, 28:510-22. 10.3122\/jabfm.2015.04.140297","journal-title":"J Am Board Fam Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2020.20196","article-title":"Atrial fibrillation for internists: current practice","volume":"150","author":"Meyre P","year":"2020","unstructured":"Meyre P, Conen D, Osswald S, K\u00fchne M, Meyer-Z\u00fcrn C. Atrial fibrillation for internists: current practice. Swiss Med Wkly. 2020, 150:w20196. 10.4414\/smw.2020.20196","journal-title":"Swiss Med Wkly"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003560","article-title":"Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry","volume":"5","author":"Bassand JP","year":"2021","unstructured":"Bassand JP, Virdone S, Badoz M, et al.. Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry. Blood Adv. 2021, 5:1081-91. 10.1182\/bloodadvances.2020003560","journal-title":"Blood Adv"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00879-x","article-title":"Drug-drug interactions with direct oral anticoagulants","volume":"59","author":"Foerster KI","year":"2020","unstructured":"Foerster KI, Hermann S, Mikus G, Haefeli WE. Drug-drug interactions with direct oral anticoagulants. Clin Pharmacokinet. 2020, 59:967-80. 10.1007\/s40262-020-00879-x","journal-title":"Clin Pharmacokinet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-020-00114-1","article-title":"NOACs: an emerging class of oral anticoagulants-a review article","volume":"6","author":"Paul C","year":"2020","unstructured":"Paul C, Baby M, Anthraper AR, Krishnakumar K. NOACs: an emerging class of oral anticoagulants-a review article. Futur J Pharm Sci. 2020, 6:95. 10.1186\/s43094-020-00114-1","journal-title":"Futur J Pharm Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2217\/fca-2021-0120","article-title":"Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis","volume":"18","author":"Deitelzweig S","year":"2022","unstructured":"Deitelzweig S, Bergrath E, di Fusco M, et al.. Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis. Future Cardiol. 2022, 18:393-405. 10.2217\/fca-2021-0120","journal-title":"Future Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1334812","article-title":"Anticoagulation therapy for atrial fibrillation","volume":"39","author":"Hylek EM","year":"2013","unstructured":"Hylek EM. Anticoagulation therapy for atrial fibrillation. Semin Thromb Hemost. 2013, 39:147-52. 10.1055\/s-0033-1334812","journal-title":"Semin Thromb Hemost"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.325.7371.1022","article-title":"Antithrombotic therapy for atrial fibrillation","volume":"325","author":"Lip GY","year":"2002","unstructured":"Lip GY, Hart RG, Conway DS. Antithrombotic therapy for atrial fibrillation. BMJ. 2002, 325:1022-5. 10.1136\/bmj.325.7371.1022","journal-title":"BMJ"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvab044","article-title":"Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials","volume":"8","author":"Benz AP","year":"2022","unstructured":"Benz AP, Johansson I, Dewilde WJ, et al.. Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials. Eur Heart J Cardiovasc Pharmacother. 2022, 8:648-59. 10.1093\/ehjcvp\/pvab044","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12185784","article-title":"Atrial fibrillation and ischemic stroke despite oral anticoagulation","volume":"12","author":"Galea R","year":"2023","unstructured":"Galea R, Seiffge D, R\u00e4ber L. Atrial fibrillation and ischemic stroke despite oral anticoagulation. J Clin Med. 2023, 12:5784. 10.3390\/jcm12185784","journal-title":"J Clin Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001261","article-title":"Correction to: Status and future directions for balloon pulmonary angioplasty in chronic thromboembolic pulmonary disease with and without pulmonary hypertension: a scientific statement from the American Heart Association","volume":"149","author":"Aggarwal V","year":"2024","unstructured":"Aggarwal V, Giri J, Visovatti SH, et al.. Correction to: Status and future directions for balloon pulmonary angioplasty in chronic thromboembolic pulmonary disease with and without pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2024, 149:e1412. 10.1161\/CIR.0000000000001261","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-301799","article-title":"Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure","volume":"98","author":"Mahajan R","year":"2012","unstructured":"Mahajan R, Brooks AG, Sullivan T, et al.. Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure. Heart. 2012, 98:1120-6. 10.1136\/heartjnl-2012-301799","journal-title":"Heart"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"Whitlock RP","year":"2021","unstructured":"Whitlock RP, Belley-Cote EP, Paparella D, et al.. Left atrial appendage occlusion during cardiac surgery to prevent stroke. N Engl J Med. 2021, 384:2081-91. 10.1056\/NEJMoa2101897","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000015698.54752.6d","article-title":"Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience","volume":"105","author":"Sievert H","year":"2002","unstructured":"Sievert H, Lesh MD, Trepels T, et al.. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation. 2002, 105:1887-9. 10.1161\/01.cir.0000015698.54752.6d","journal-title":"Circulation"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005359","article-title":"Percutaneous left atrial appendage closure: current devices and clinical outcomes","volume":"10","author":"Asmarats L","year":"2017","unstructured":"Asmarats L, Rod\u00e9s-Cabau J. Percutaneous left atrial appendage closure: current devices and clinical outcomes. Circ Cardiovasc Interv. 2017, 10:10.1161\/CIRCINTERVENTIONS.117.005359","journal-title":"Circ Cardiovasc Interv"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.03.035","article-title":"Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)","volume":"61","author":"Reddy VY","year":"2013","unstructured":"Reddy VY, M\u00f6bius-Winkler S, Miller MA, et al.. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol. 2013, 61:2551-6. 10.1016\/j.jacc.2013.03.035","journal-title":"J Am Coll Cardiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.4244\/EIJY15M01_06","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug","volume":"11","author":"Tzikas A","year":"2016","unstructured":"Tzikas A, Shakir S, Gafoor S, et al.. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention. 2016, 11:1170-9. 10.4244\/EIJY15M01_06","journal-title":"EuroIntervention"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.4022\/jafib.1806","article-title":"LARIAT trial updates","volume":"11","author":"Musat D","year":"2018","unstructured":"Musat D, Mittal S. LARIAT trial updates. J Atr Fibrillation. 2018, 11:1806. 10.4022\/jafib.1806","journal-title":"J Atr Fibrillation"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70017-0","article-title":"Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial","volume":"11","author":"Diener HC","year":"2012","unstructured":"Diener HC, Eikelboom J, Connolly SJ, et al.. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. Lancet Neurol. 2012, 11:225-31. 10.1016\/S1474-4422(12)70017-0","journal-title":"Lancet Neurol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2020.09.051","article-title":"Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation","volume":"14","author":"Nielsen-Kudsk JE","year":"2021","unstructured":"Nielsen-Kudsk JE, Korsholm K, Damgaard D, Valentin JB, Diener HC, Camm AJ, Johnsen SP. Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation. JACC Cardiovasc Interv. 2021, 14:69-78. 10.1016\/j.jcin.2020.09.051","journal-title":"JACC Cardiovasc Interv"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli AP","year":"2022","unstructured":"Carnicelli AP, Hong H, Connolly SJ, et al.. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation. 2022, 145:242-55. 10.1161\/CIRCULATIONAHA.121.056355","journal-title":"Circulation"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart RG","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007, 146:857-67. 10.7326\/0003-4819-146-12-200706190-00007","journal-title":"Ann Intern Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.v63i4.941","article-title":"Explaining the RE-LY trial","volume":"63","author":"Eikelboom JW","year":"2010","unstructured":"Eikelboom JW, Connolly SJ. Explaining the RE-LY trial. Can J Hosp Pharm. 2010, 63:334-6. 10.4212\/cjhp.v63i4.941","journal-title":"Can J Hosp Pharm"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel MR","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, et al.. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011, 365:883-91. 10.1056\/NEJMoa1009638","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-92. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006703","article-title":"Impact of spontaneous extracranial bleeding events on health state utility in patients with atrial fibrillation: results from the ENGAGE AF-TIMI 48 trial","volume":"6","author":"Wang K","year":"2017","unstructured":"Wang K, Li H, Kwong WJ, et al.. Impact of spontaneous extracranial bleeding events on health state utility in patients with atrial fibrillation: results from the ENGAGE AF-TIMI 48 trial. J Am Heart Assoc. 2017, 6:989-92. 10.1161\/JAHA.117.006703","journal-title":"J Am Heart Assoc"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.994085","article-title":"Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: a Belgian nationwide cohort study","volume":"9","author":"Grymonprez M","year":"2022","unstructured":"Grymonprez M, Capiau A, Steurbaut S, Mehuys E, Boussery K, De Backer TL, Lahousse L. Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: a Belgian nationwide cohort study. Front Cardiovasc Med. 2022, 9:994085. 10.3389\/fcvm.2022.994085","journal-title":"Front Cardiovasc Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0741-3","article-title":"Cost-effectiveness analysis of direct-acting oral anticoagulants for stroke prevention in Thai patients with non-valvular atrial fibrillation and a high risk of bleeding","volume":"37","author":"Rattanachotphanit T","year":"2019","unstructured":"Rattanachotphanit T, Limwattananon C, Waleekhachonloet O, Limwattananon P, Sawanyawisuth K. Cost-effectiveness analysis of direct-acting oral anticoagulants for stroke prevention in Thai patients with non-valvular atrial fibrillation and a high risk of bleeding. Pharmacoeconomics. 2019, 37:279-89. 10.1007\/s40273-018-0741-3","journal-title":"Pharmacoeconomics"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy11010034","article-title":"Practical guide for anticoagulant and antiplatelet reversal in clinical practice","volume":"11","author":"Aldhaeefi M","year":"2023","unstructured":"Aldhaeefi M, Badreldin HA, Alsuwayyid F, et al.. Practical guide for anticoagulant and antiplatelet reversal in clinical practice. Pharmacy (Basel). 2023, 11:34. 10.3390\/pharmacy11010034","journal-title":"Pharmacy (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/270497-novel-anticoagulants-for-stroke-prevention-in-atrial-fibrillation-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T11:05:39Z","timestamp":1721905539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/270497-novel-anticoagulants-for-stroke-prevention-in-atrial-fibrillation-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":49,"URL":"https:\/\/doi.org\/10.7759\/cureus.65347","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,25]]}}}